Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection

Western Journal of Emergency Medicine

Volumn 16, Issue 1, 2015, Pages 89-97

  Talan, David A ^a   Salhi, Bisan A ^b   Moran, Gregory J ^a   Mower, William R ^c   Hsieh, Yu Hsiang ^d   Krishnadasan, Anusha ^a   Rothman, Richard E ^d  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Abscess; Admission; Cellulitis; Emergency department; Hospitalization; Methicillin resistant staphylococcus aureus; MRSA; Skin and soft tissue infection; SSTI; Wound infection

Indexed keywords

ANTIBIOTIC AGENT;

AGED; AMPUTATION; ANTIBIOTIC THERAPY; ARTICLE; COMORBIDITY; EMERGENCY WARD; ERYTHEMA; FEMALE; FEVER; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; SKIN INFECTION; SOFT TISSUE INFECTION; SYMPTOMATOLOGY; TACHYCARDIA; TACHYPNEA; TREATMENT FAILURE; ADOLESCENT; ADULT; CLINICAL PRACTICE; EMERGENCY HEALTH SERVICE; MIDDLE AGED; PROSPECTIVE STUDY; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; UNITED STATES; YOUNG ADULT;

EID: 84921638188     PISSN: 1936900X     EISSN: 19369018     Source Type: Journal    
DOI: 10.5811/westjem.2014.11.24133     Document Type: Article

References (35)

1. Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008;51:291-8.
2. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666-74.
3. Edelsberg J, Taneja C, Zervos M, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis. 2009;15:1516-8.
4. Lindenauer PK, Lagu T, Shieh MS, et al. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009. JAMA. 2012;307:1405-13.
5. LaPensee KT, Fan W, Wang Y. Economic burden of hospitalization with antibiotic treatment of ABSSSI in the United States: an analysis of the Premier hospital database. Value Health. 15(4)2012;A240-A241.
6. Hauck K, Zhao X. How dangerous is a day in hospital? A model of adverse events and length of stay for medical inpatients. Med Care. 2011;49:1068-75.
7. Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010;51(Suppl2):S198-208.
8. Nguyen HH. Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic center. Clin Infect Dis. 2010;51(Suppl2):S220-3.
9. Corey GR, Kabler H, Mehra P, et al. Single-dose oritavancin in the treatment of acute bacterial skin infections. N Engl J Med. 2014;370:2180-90.
10. Boucher HW, Wilcox M, Talbot GH, et al. Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med. 2014;370:2169-79.
11. Talan DA, Moran GJ, Mower WR, et al. EMERGEncy ID NET: An emergency department-based emerging infections sentinel network. Clin Infect Dis. 1999;28:401-2.
12. Talan DA, Krishnadasan A, Gorwitz RJ, et al. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis. 2011;53:144-9.
13. Liu C, Bayer A, Cosgrove SE, et al. Infectious diseases society of america. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18-55.
14. United States Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Uncomplicated and Complicated Skin and Skin Structure Infections - Developing Drugs for Treatment. Draft Guidance [monograph]. 1998. Available at: http://www.fda.gov/ohrms/dockets/98fr/2566dft.pdf. Accessed Apr 6, 2014.
15. http://vassarstats.net/utest.html; Accessed Apr 15, 2014.
16. Hair JF, Tatham RL, Anderson RE, et al. Multivariate Data Analysis, 5th Ed. Prentice-Hall, Englewood Cliffs, NJ, 1998.
17. Khachatryan A, Patel D, Stephens J, et al. Skin and skin structure infections in the emergency department: who gets admitted? Acad Emerg Med. 2014;21(S1):S50.
18. Dean NC, Jones JP, Aronsky D, et al. Hospital admission decision for patients with community-acquired pneumonia: variability among physicians in an emergency department. Ann Emerg Med. 2012;59:35-41.
19. Atlas SJ, Benzer TI, Borowsky LH, et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med. 1998;158:1350-6.
20. Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest. 2005;127:1260-70.
21. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275:134-41.
22. Sabbaj A, Jensen B, Browning MA, et al. Soft tissue infections and emergency department disposition: predicting need for inpatient admission. Acad Emerg Med. 2009;16:1290-7.
23. Peterson D, McLeod S, Woolfrey K, et al. Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis. Acad Emerg Med. 2014;21:526-31.
24. Itani KM, Biswas P, Reisman A, et al. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, casecontrol analysis. Clin Ther. 2012;34:1667-73.
25. Figtree M, Konecny P, Jennings Z, et al. Risk stratification and outcome of cellulitis admitted to hospital. J Infect. 2010;60:431-9.
26. Carratala J, Roson B, Fernandez-Sabe N, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis. 2003;22:151-7.
27. Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32:1535-41.
28. Eron LJ, Lipsky BA, Low DE et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003;52(SupplS1):i3-17.
29. Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol. 2008;19:173-84.
30. CREST (Clinical Resource Efficiency Support Team); Marwick C, Broomhall J, et al. Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. J Antimicrob Chemother. 2011;66:387-97.
31. Marwick C, Broomhall J, McCowan C, et al. Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. J Antimicrob Chemother. 2011;66:387-97.
32. Koerner R, Johnson AP. Changes in the classification and management of skin and soft tissue infections. J Antimicrob Chemother. 2011;66:232-4.
33. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005:41:1373-1406.
34. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243-50.
35. Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-acquired pneumonia intervention trial assessing levofloxacin. JAMA. 2000;283:749-55.